Physician profile
James Kong
NPI 1265417000
$3,782.88
in general payments reported to CMS, 2019-2025
17 companies · $667 in 2025
The $667 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $242 · 2021: $43.30 · 2022: $14.42 · 2023: $605 · 2024: $1,822 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,873 · Entertainment: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,873.20 |
| Entertainment | $221.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $1,000.00 | 2024 | |
| Sun Pharmaceutical Industries INC. | $443.73 | 2023-2025 | Cequa |
| Alcon Vision LLC | $368.26 | 2019-2025 | Total30, Precision7, Precision 1 |
| Optos, INC. | $287.24 | 2020-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $251.92 | 2023-2024 | Acuvue |
| Dompe US, INC. | $237.59 | 2024 | Oxervate |
| Coopervision INC. | $210.32 | 2023-2025 | Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $134.20 | 2022-2023 | Infuse |
| Glaukos Corporation | $125.10 | 2025 | Idosetr |
| Novartis Pharmaceuticals Corporation | $125.00 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $123.41 | 2023 | |
| Harrow Eye, LLC | $98.55 | 2025 | Vevye |
| Quidel Corporation | $97.55 | 2019 | |
| Genzyme Corporation | $94.87 | 2019 | |
| Aerie Pharmaceuticals, INC. | $90.68 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $51.16 | 2020 | |
| Synergeyes, INC. | $43.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.